ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
131.38
+1.98 (1.53%)
Mar 25, 2026, 4:00 PM EDT - Market closed
ICU Medical Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$182.25
Upside
+38.72%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Maintains $175 → $180 | Buy | Maintains | $175 → $180 | +37.01% | Feb 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $172 → $178 | Buy | Maintains | $172 → $178 | +35.48% | Feb 20, 2026 |
| Keybanc | Keybanc | Buy Maintains $173 → $175 | Buy | Maintains | $173 → $175 | +33.20% | Nov 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $153 → $172 | Buy | Maintains | $153 → $172 | +30.92% | Nov 7, 2025 |
| Keybanc | Keybanc | Buy Maintains $191 → $173 | Buy | Maintains | $191 → $173 | +31.68% | Oct 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $145 → $153 | Buy | Maintains | $145 → $153 | +16.46% | Sep 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $145 | Buy | Initiates | $145 | +10.37% | Aug 15, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $187 → $180 | Strong Buy | Maintains | $187 → $180 | +37.01% | Aug 8, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $197 → $187 | Strong Buy | Maintains | $197 → $187 | +42.34% | May 9, 2025 |
| Keybanc | Keybanc | Buy Maintains $209 → $191 | Buy | Maintains | $209 → $191 | +45.38% | Apr 21, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 8, 2025 |
| Raymond James | Raymond James | Buy → Strong Buy Maintains $205 → $197 | Buy → Strong Buy | Maintains | $205 → $197 | +49.95% | Mar 12, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $200 | Hold → Strong Buy | Upgrades | $200 | +52.23% | Dec 11, 2024 |
| Keybanc | Keybanc | Buy Maintains $198 → $209 | Buy | Maintains | $198 → $209 | +59.08% | Nov 13, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| Keybanc | Keybanc | Buy Maintains $147 → $198 | Buy | Maintains | $147 → $198 | +50.71% | Oct 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.